Recent updates on COVID-19 vaccination

  • Update 20/05/2021 – Community Pharmacy Scotland have advised on changes to the ordering of PPE in pharmacies.  Your orders will soon require to be placed via the pharmacy NHS Generic Mailbox

  • Update 07/05/2021 – JCVI has issued advice to the UK government on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40
  • Update 17/04/2021 – JCVI announcement regarding COVID-19 vaccination during pregnancy and next steps
  • Update 15/04/2021 – Frequently Asked Questions: MHRA and JCVI guidance on AstraZeneca COVID-19 vaccine and very rare clotting disorders

Scottish Government useful links:

 

NPA webinar – Understanding COVID-19 vaccinations and addressing vaccine hesitancy

 

NPA Resources

 

Please see below for useful resources

Regulatory - General Pharmaceutical Council (GPhC) COVID-19 vaccination information/guidance/FAQs

Guidance for those involved in the COVID-19 vaccination programme. Covering information on assurance and governance to ensure safety and accountability.

Indemnity arrangements for COVID-19 vaccination programme

NHSE&I, DHSC, and NHS Resolution have issued a joint letter about the indemnity arrangements that are in place to cover the COVID-19 vaccination programme, which includes community pharmacy.

NPA COVID-19 vaccination training

Information on the suitability and content of this 2 hour virtual training session and additional COVID-19 training resources. From this page you can also link to details of our full vaccination training which includes COVID specific vaccination information.

JCVI issues interim advice on Phase 2 of COVID-19 vaccination programme rollout

The Joint Committee on Vaccination and Immunisation (JCVI) has considered the evidence for Phase 2 of the UK’s COVID-19 vaccination programme

COVID-19 vaccine hesitancy

Information and guidance on providing support to patients/staff who have COVID-19 vaccine hesitancy

AstraZeneca COVID-19 vaccine and blood clots – updated advice issued by JCVI and MHRA

JCVI and MHRA have updated their information on the AstraZenaca COVID-19 vaccine and the extremely rare and unlikely link with blood clots. Updated advice for pharmacy teams

Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the UK government on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40